/
/
/

Venmax Drugs And Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)15.02
Volume (₹)3,096.00
High (₹)16.00
Upper Circuit18.02
Low (₹)14.90
Lower Circuit12.02
Prev Close15.02
52W High (₹)31.49
Price14.90
52W Low (₹)12.71

Share Market Cap & Key Ratios Overview

M.Cap (₹)21.75 Cr
Div. Yield (%)0.00
PE Ratio77.42
Debt to Equity-0.08
Price to Book-22.62
Book Value-1.26
EPS (TTM)0.19
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
VENMAX-XNSE
LTP
1W Low
1W High
Market cap (₹)
1732.3-24.6 (-1.40%)
1725.70
1777.05
4,24,466Cr
9048.7-277.3 (-2.97%)
9028
9450
2,46,222Cr
4577.35-82.65 (-1.77%)
4557.10
4680.30
1,76,301Cr
1135+19.9 (1.78%)
1108
1139
1,12,818Cr
2033+0.9 (0.04%)
2008.70
2071
1,10,823Cr
1306.6+3.3 (0.25%)
1300.25
1330.60
1,07,447Cr
1214.25+19.15 (1.60%)
1195.65
1250.95
1,03,471Cr
2324.95-44.05 (-1.86%)
2317.80
2425.05
97,850Cr
1666.1-20 (-1.19%)
1660.15
1714.90
96,836Cr
1946.7-13.3 (-0.68%)
1925.85
1966.05
89,629Cr
14.9+0.5 (3.47%)
13.33
16.29
22Cr

Key Highlights of Venmax Drugs And Pharmaceuticals Ltd Balance Sheet

Venmax Drugs And Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹5.24Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.24Cr, and the reserves and surplus of the company is -₹5.9Cr.

The company has its non-current liabilities with total liabilities of ₹5.17Cr as of 2025-03-31.

The current liabilities are ₹75.67Lakh as of 2025-03-31. At the same time, current assets are ₹5.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹4.05Lakh, provided in the Venmax Drugs And Pharmaceuticals Ltd financial statements.